Characteristics and Treatment Patterns of Patients With Chronic Obstructive Pulmonary Disease (COPD), Initiating Tio+Olo or Other Maintenance Therapies in the US and the UK: A Retrospective Claims Database Study

Characteristics and Treatment Patterns of Patients With Chronic Obstructive Pulmonary Disease (COPD), Initiating Tio+Olo or Other Maintenance Therapies in the US and the UK: A Retrospective Claims Database Study

The primary objectives of the study are to use US and UK data to describe the characteristics of Chronic Obstructive Pulmonary Disease (COPD) patients according to various demographic, lifestyle, clinical, and medication use.

Inclusion criteria:

• parent cohort

  -- COPD diagnosis

• child cohort

  -- any initiation of first maintenance therapy after July 1, 2015

• grandchild cohort -- any initiation of second maintenance therapy after August 2, 2015

Exclusion criteria:

- parent cohort

• age <40 on index date
• any COPD diagnosis in baseline
• any use of long-acting muscarinic antagonists (LAMA), long-acting beta-agonists (LABA), or inhaled corticosteroid (ICS) in baseline
• <365 days of continuous medical and pharmacy coverage